• Our offerings
    • Market Access Strategy, HTA, and Health Economics
    • Nordic RWE & Evidence Generation
    • AI & Dashboard Solutions
    • Policy Shaping & Life Science Consulting
  • Our work
  • The latest
  • Our people
  • Careers
  • Contact us

Lif launches vaccine proposal: Denmark falls behind on vaccination efforts

NICE greenlights Rystiggo for uncontrolled gMG via interim NHS funding

Cancer care needs innovation that translates into real patient benefit

TLV revises guidelines to price adjustments for high sales value

CHMP issues positive opinion for five new medicines and nine extensions

Palko begins work on Breyanzi recommendation

Sweden lacks a national adult vaccination program

NHTA collaborates with DTU Computerome for Nordic Real-world evidence studies

EFPIA: Invest early in health to save later

US MFN pricing could make Sweden a global price anchor

Previous 1 2 3 4 5 6 7 8 Next

Leveraging Nordic data & insights to support your Market Access goals.

NHTA Copenhagen
Nelson Mandelas Allé 14, 2450 Copenhagen SV, Denmark

NHTA Stockholm
Vasagatan 10, 5th floor, 111 20 Stockholm, Sweden

Contact us

+45 44 222 777
CVR: 39842882

+46 70-322 66 65
Org.nr: 559438-4207

contact@nhta.com

Navigation

  • Our offerings
  • Our work
  • The latest
  • Our people
  • Careers
  • Contact us

Follow us on LinkedIn

LinkedIn
  • Data Protection Policy
  • Cookie Policy